Till sidans huvudinnehåll

News

Stay updated with our news and current events.

The RECOVERY Study

Sweden is joining the RECOVERY study, which is now being expanded to include patients across Europe. The study invest...

Why Conduct Clinical Trials in Sweden

ACTION Sweden, together with the Swedish Pharmaceutical Society (Apotekarsocieteten), has published a document on con...

Awarded Network Support from SLS

ACTION Sweden has been granted network support from the Swedish Society of Medicine (SLS) for 2025–2026. In addition,...

Representative in the Ecraid Coordinating Committee

As a representative of ACTION Sweden, Pontus Nauclér is part of the Ecraid Coordinating Committee.On October 1st 2024...

Virtual Seminar on Staphylococcus aureus Treatment Studies

On September 25th 2024, ACTION Sweden hosted a virtual seminar on studies concerning the treatment of serious infecti...

New Study: SNAP – The World’s Largest Clinical Trial on S. aureus Bacteremia

ACTION Sweden supports the study, which in Sweden is led by Jonas Tverring, Infectious Diseases Clinic, Helsingborg H...

New Study: COMeBAC – Penicillin for Penicillin-Sensitive S. aureus

ACTION Sweden supports the study led by Malin Hagstrand Aldman, Infectious Diseases Clinic, Skåne University Hospital...

Ecraid Offers Online Course

Adaptive Clinical Trial DesignsA six-part online course introducing the future of clinical trials Dates31st January –...

Roundtable Discussion – ACTION Sweden, the Swedish Pharmaceutical Society, and Industry Partners

ACTION Sweden and the Swedish Pharmaceutical Society (Apotekarsocieteten) invited representatives from the pharmaceut...

Article About ACTION Sweden in Infektionsläkaren

Read the article in Infektionsläkaren No. 1 – 2023 here (in Swedish)